In 1967, following the sale of the company, Levin founded Biospherics Research Inc. (now Spherix Inc.), where he was CEO and President until 2003, and served as Chairman of the Board until 2007.
ChromaDex Corporation� (OTCBB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to numerous end markets, has finally solved the puzzle of how to produce nicotinimide riboside (NR) on a ...
REDONDO BEACH, CA--(Marketwired - May 21, 2013) - ChromaDex Corporation ( OTCQB : CDXC) Director Michael Brauser purchased 25,000 shares of common stock on the open market on May 13th, according to a Form 4 filing made with the SEC.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.